BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 29084250)

  • 21. Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein.
    Verma D; Li DJ; Krueger B; Renne R; Swaminathan S
    J Virol; 2015 Feb; 89(3):1688-702. PubMed ID: 25410858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing.
    Majerciak V; Yamanegi K; Allemand E; Kruhlak M; Krainer AR; Zheng ZM
    J Virol; 2008 Mar; 82(6):2792-801. PubMed ID: 18184716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing.
    Majerciak V; Zheng ZM
    Front Biosci (Landmark Ed); 2009 Jan; 14(4):1516-28. PubMed ID: 19273144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of cellular export factor REF/Aly by Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 protein is not required for efficient KSHV lytic replication.
    Li DJ; Verma D; Swaminathan S
    J Virol; 2012 Sep; 86(18):9866-74. PubMed ID: 22761374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
    Li X; Huang L; Xiao Y; Yao X; Long X; Zhu F; Kuang E
    J Virol; 2019 May; 93(10):. PubMed ID: 30842327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses.
    Rabouw HH; Langereis MA; Knaap RC; Dalebout TJ; Canton J; Sola I; Enjuanes L; Bredenbeek PJ; Kikkert M; de Groot RJ; van Kuppeveld FJ
    PLoS Pathog; 2016 Oct; 12(10):e1005982. PubMed ID: 27783669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus.
    Majerciak V; Pripuzova N; McCoy JP; Gao SJ; Zheng ZM
    J Virol; 2007 Feb; 81(3):1062-71. PubMed ID: 17108026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of a Coregulatory Interaction between Kaposi's Sarcoma-Associated Herpesvirus ORF45 and the Viral Protein Kinase ORF36.
    Avey D; Tepper S; Pifer B; Bahga A; Williams H; Gillen J; Li W; Ogden S; Zhu F
    J Virol; 2016 Jul; 90(13):5953-5964. PubMed ID: 27099309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The KSHV RNA regulator ORF57: target specificity and its role in the viral life cycle.
    Vogt C; Bohne J
    Wiley Interdiscip Rev RNA; 2016; 7(2):173-85. PubMed ID: 26769399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural identification of conserved RNA binding sites in herpesvirus ORF57 homologs: implications for PAN RNA recognition.
    Tunnicliffe RB; Levy C; Ruiz Nivia HD; Sandri-Goldin RM; Golovanov AP
    Nucleic Acids Res; 2019 Feb; 47(4):1987-2001. PubMed ID: 30462297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF90 exerts antiviral activity through regulation of PKR phosphorylation and stress granules in infected cells.
    Wen X; Huang X; Mok BW; Chen Y; Zheng M; Lau SY; Wang P; Song W; Jin DY; Yuen KY; Chen H
    J Immunol; 2014 Apr; 192(8):3753-64. PubMed ID: 24623135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining the Role of Stress Granules in Innate Immune Suppression by the Herpes Simplex Virus 1 Endoribonuclease VHS.
    Burgess HM; Mohr I
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi's sarcoma-associated herpesvirus ORF57 protein protects viral transcripts from specific nuclear RNA decay pathways by preventing hMTR4 recruitment.
    Ruiz JC; Hunter OV; Conrad NK
    PLoS Pathog; 2019 Feb; 15(2):e1007596. PubMed ID: 30785952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase.
    Burýsek L; Pitha PM
    J Virol; 2001 Mar; 75(5):2345-52. PubMed ID: 11160738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seneca Valley Virus 3C Protease Inhibits Stress Granule Formation by Disrupting eIF4GI-G3BP1 Interaction.
    Wen W; Zhao Q; Yin M; Qin L; Hu J; Chen H; Li X; Qian P
    Front Immunol; 2020; 11():577838. PubMed ID: 33133097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication.
    Nakagawa K; Narayanan K; Wada M; Makino S
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Musashi-1 promotes chemoresistant granule formation by PKR/eIF2α signalling cascade in refractory glioblastoma.
    Chen HY; Lin LT; Wang ML; Tsai KL; Huang PI; Yang YP; Lee YY; Chen YW; Lo WL; Lan YT; Chiou SH; Lin CM; Ma HI; Chen MT
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1850-1861. PubMed ID: 29486283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newcastle disease virus induces stable formation of
    Sun Y; Dong L; Yu S; Wang X; Zheng H; Zhang P; Meng C; Zhan Y; Tan L; Song C; Qiu X; Wang G; Liao Y; Ding C
    FASEB J; 2017 Apr; 31(4):1337-1353. PubMed ID: 28011649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mumps Virus Induces Protein-Kinase-R-Dependent Stress Granules, Partly Suppressing Type III Interferon Production.
    Hashimoto S; Yamamoto S; Ogasawara N; Sato T; Yamamoto K; Katoh H; Kubota T; Shiraishi T; Kojima T; Himi T; Tsutsumi H; Yokota S
    PLoS One; 2016; 11(8):e0161793. PubMed ID: 27560627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.